Business Description
Aligned Genetics Inc
ISIN : KR7238120000
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.2 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 1.09 | |||||
Interest Coverage | 15.53 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.27 | |||||
Beneish M-Score | -1.75 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.4 | |||||
3-Year EBITDA Growth Rate | 36 | |||||
3-Year EPS without NRI Growth Rate | 70.8 | |||||
3-Year Book Growth Rate | 13.4 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.62 | |||||
9-Day RSI | 57.82 | |||||
14-Day RSI | 56.72 | |||||
6-1 Month Momentum % | 15.01 | |||||
12-1 Month Momentum % | 4.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.12 | |||||
Quick Ratio | 3.39 | |||||
Cash Ratio | 2.85 | |||||
Days Inventory | 324.11 | |||||
Days Sales Outstanding | 47.68 | |||||
Days Payable | 15.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.01 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.13 | |||||
Operating Margin % | 21.93 | |||||
Net Margin % | 21.27 | |||||
FCF Margin % | 12.94 | |||||
ROE % | 10.73 | |||||
ROA % | 8.35 | |||||
ROIC % | 12.95 | |||||
ROC (Joel Greenblatt) % | 28.78 | |||||
ROCE % | 9.96 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.13 | |||||
PE Ratio without NRI | 20.19 | |||||
Shiller PE Ratio | 143.82 | |||||
Price-to-Owner-Earnings | 71.24 | |||||
PS Ratio | 4.29 | |||||
PB Ratio | 2.08 | |||||
Price-to-Tangible-Book | 2.09 | |||||
Price-to-Free-Cash-Flow | 33.19 | |||||
Price-to-Operating-Cash-Flow | 22.93 | |||||
EV-to-EBIT | 15.12 | |||||
EV-to-EBITDA | 12.88 | |||||
EV-to-Revenue | 3.62 | |||||
EV-to-FCF | 27.95 | |||||
Price-to-Projected-FCF | 4.62 | |||||
Price-to-Graham-Number | 1.37 | |||||
Price-to-Net-Current-Asset-Value | 5.45 | |||||
Price-to-Net-Cash | 12.3 | |||||
Earnings Yield (Greenblatt) % | 6.61 | |||||
FCF Yield % | 3.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aligned Genetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 15,214.699 | ||
EPS (TTM) (â‚©) | 225.5 | ||
Beta | 0.78 | ||
Volatility % | 28.68 | ||
14-Day RSI | 56.72 | ||
14-Day ATR (â‚©) | 111.804403 | ||
20-Day SMA (â‚©) | 4479.5 | ||
12-1 Month Momentum % | 4.22 | ||
52-Week Range (â‚©) | 3460 - 6175 | ||
Shares Outstanding (Mil) | 14.38 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aligned Genetics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aligned Genetics Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Aligned Genetics Inc Frequently Asked Questions
What is Aligned Genetics Inc(XKRX:238120)'s stock price today?
When is next earnings date of Aligned Genetics Inc(XKRX:238120)?
Does Aligned Genetics Inc(XKRX:238120) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |